SCHEMBL3246527

SCHEMBL3246527

S=CN(Cc1ccccc1)C1CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PC1 P35575 2/20 0.44
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
YTHDC1 Q96MU7 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
CA2 P00918 2/20 0.37
SLC18A3 Q16572 1/20 0.37
AOC3 Q16853 1/20 0.36
MGLL Q99685 2/20 0.36
GRIN2B Q13224 1/20 0.36
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALOX12 P18054 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3247714 0.91 G6PC1 (0.51) G6PC1ALDH1A1MEN1KMT2ASLC18A3
SCHEMBL3240531 0.81 SLC6A2 (0.44) G6PC1ALDH1A1TSHRMEN1KMT2A
SCHEMBL14855420 0.76 G6PC1 (0.46) G6PC1ALDH1A1MEN1KMT2ASLC6A2
SCHEMBL17984965 0.75 KMT2A (0.40) G6PC1ALDH1A1TSHRMEN1KMT2A
SCHEMBL14855136 0.74 G6PC1 (0.49) G6PC1ALDH1A1MEN1KMT2ASLC6A2
SCHEMBL3238188 0.73 G6PC1 (0.51) G6PC1ALDH1A1MEN1KMT2ASLC6A2
SCHEMBL14855858 0.73 G6PC1 (0.51) G6PC1ALDH1A1MEN1KMT2ASLC6A2
SCHEMBL3376962 0.73 YTHDC1 (0.58) G6PC1ALDH1A1TSHRMEN1KMT2A
SCHEMBL12745062 0.73 ALDH1A1 (0.46) G6PC1ALDH1A1TSHRMEN1KMT2A
SCHEMBL8620642 0.70 SLC6A2 (0.56) G6PC1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1167366-B1 AMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2010-05-05 EP disclosed
US-6562849-B1 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc. SANKYO COMPANY, LIMITED (JP) 2003-05-13 US disclosed
US-20030078426-A1 Amine derivative compounds SANKYO COMPANY, LIMITED (JP) 2003-04-24 US disclosed
EP-1167366-A1 AMINE DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078426-A1 Amine derivative compounds H1-10, APOB, PRMT1 G6PC1 1282/4885ALDH1A1 874/4885TSHR 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.